|
gptkbp:instanceOf
|
gptkb:chemical_compound
Hallucinogen
|
|
gptkbp:abusePotential
|
low
|
|
gptkbp:aroma
|
odorless
|
|
gptkbp:ATCCode
|
N01AX63
|
|
gptkbp:CASNumber
|
50-37-3
|
|
gptkbp:chemicalFormula
|
C20H25N3O
|
|
gptkbp:color
|
colorless
|
|
gptkbp:discoveredBy
|
gptkb:Albert_Hofmann
|
|
gptkbp:discoveredIn
|
1938
|
|
gptkbp:duration_of_action
|
8-12 hours
|
|
gptkbp:effect
|
euphoria
hallucinations
synesthesia
altered perception
spiritual experiences
|
|
gptkbp:excretion
|
kidneys
|
|
gptkbp:firstSynthesized
|
gptkb:Sandoz_Laboratories
|
|
gptkbp:flavor
|
slightly bitter
|
|
gptkbp:halfLife
|
3-5 hours
|
|
gptkbp:hasInChIKey
|
OIGHWRSKBELZPM-UHFFFAOYSA-N
|
|
gptkbp:hasSMILES
|
CCN(CC)C(=O)[C@@H]1CN(C)C2=C3C=CC4=CC=CC=C4N3C=C2C1
|
|
gptkbp:hasStreet
|
gptkb:carboxylic_acid
|
|
https://www.w3.org/2000/01/rdf-schema#label
|
LSD-55
|
|
gptkbp:IUPACName
|
(6aR,9R)-N,N-diethyl-7-methyl-4,6,6a,7,8,9-hexahydroindolo[4,3-fg]quinoline-9-carboxamide
|
|
gptkbp:legalStatus
|
gptkb:Schedule_I_(US)
gptkb:Class_A_(UK)
|
|
gptkbp:meltingPoint
|
80-85°C
|
|
gptkbp:metabolism
|
liver
|
|
gptkbp:molecularWeight
|
323.43 g/mol
|
|
gptkbp:notableFor
|
gptkb:MKUltra_experiments
counterculture of the 1960s
|
|
gptkbp:origin
|
derived from ergot fungus
|
|
gptkbp:otherName
|
gptkb:Lysergic_acid_diethylamide
LSD
|
|
gptkbp:PubChem_CID
|
gptkb:CHEMBL98
5761
CHEBI:27927
|
|
gptkbp:routeOfAdministration
|
oral
intravenous
sublingual
|
|
gptkbp:solubility
|
ethanol (soluble)
water (slightly soluble)
|
|
gptkbp:toxicity
|
low acute toxicity
|
|
gptkbp:UNII
|
D839GV0YJ7
|
|
gptkbp:usedFor
|
psychedelic research
recreational drug
|
|
gptkbp:bfsParent
|
gptkb:USS_Lake_St._Clair_(LSD-55)
|
|
gptkbp:bfsLayer
|
6
|